Skip to main content
Download PDF
  • Research Article
  • Open access
  • Published:

Nigella sativa Extract and Thymoquinone Regulate Inflammatory Cytokine and TET-2 Expression in Endothelial Cells

Artery Research volume 25, pages 157–163 (2019)Cite this article

Abstract

Numerous natural compounds including Nigella sativa (N. sativa) demonstrate anti-infammatory and anti-diabetic antiangiogenic properties. Lipopolysaccharide (LPS) mediated inflammation is regarded as an important contributor to the inflammation that is associated with the development of arteriosclerosis. In this study, it was hypothesised that N. sativa Extract (NSE) and its main active component Thymoquinone (TQ) could potentially inhibit LPS mediated inflammatory cytokine secretion and monocyte recruitment factors and monocyte in Human Vascular Endothelial Cell (HECV) lines. In addition the Ten-Eleven Translocation (TET-2) an epigenetic regulator, increasingly regarded has having a major role in both the regulation of cytokine secretion and in the development of atherosclerosis through its ability to inhibit the inflammasome Nod-like Receptor Protein 3 (NLRP3) and Interleukin-1β (IL-1β) secretion was investigated. NSE significantly inhibited the production of both IL-6 and -8 and both NSE and TQ inhibited the gene expression of vascular endothelial growth factor and monocyte chemotactic protein-1 in HECV cells. NSE and TQ inhibited the gene expression of NLRP3 and IL-1β and significantly upregulated the gene expression of TET-2 in the presence of LPS. To conclude, NSE and TQ attenuated inflammatory and monocyte recruitment response and also demonstrate a potentially important role in regulating both NLRP3 and TET-2 expression.

References

  1. Tavakkoli A, Mahdian V, Razavi BM, Hosseinzadeh H. Review on clinical trials of black seed (Nigella sativa) and its active constituent, thymoquinone. J Pharmacopuncture 2017;20:179–93.

    Google Scholar 

  2. Shuid AN, Mohamed N, Mohamed IN, Othman F, Suhaimi F, Mohd Ramli ES, et al. Nigella sativa: a potential antiosteoporotic agent. Evid Based Complement Alternat Med 2012;2012:696230.

    Google Scholar 

  3. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, et al. A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pac J Trop Biomed 2013;3:337–52.

    Google Scholar 

  4. Razavi BM, Hosseinzadeh H. A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome. J Endocrinol Invest 2014;37:1031–40.

    Google Scholar 

  5. Ismail N, Abdel–Mottaleb Y, Eissa Ahmed AA, El-Maraghy NN. Novel combination of thymoquinone and resveratrol enhances anticancer effect on hepatocellular carcinoma cell line. Future J Pharm Sci 2018;4:41–6.

    Google Scholar 

  6. Herrero-Fernandez B, Gomez-Bris R, Somovilla-Crespo B, Gonzalez-Granado JM. Immunobiology of atherosclerosis: a complex net of interactions. Int J Mol Sci 2019;20:pii: E5293.

  7. Talepoor AG, Fouladseresht H, Khosropanah S, Doroudchi M. Immune-inflammation in atherosclerosis: a new twist in the old tale. Endocr Metab Immune Disord Drug Targets 2019;19:1.

    Google Scholar 

  8. Poston RN. Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review. Cardiovasc Endocrinol Metab 2019;8:51–61.

    Google Scholar 

  9. Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 2008;18:228–32.

    Google Scholar 

  10. Čejková S, Králová-Lesná I, Poledne R. Monocyte adhesion to the endothelium is an initial stage of atherosclerosis development. Cor et Vasa 2016;58:e419–e25.

    Google Scholar 

  11. Woollard KJ, Geissman F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010;7:77–86.

    Google Scholar 

  12. Boisvert WA, Curnss LK, Terkeltaub RA. Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol Res 2000;21:129–37.

    Google Scholar 

  13. Niu J, Azfer A, Zhelyabovska O, Fatma S, Kolattukudy PE. Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J Biol Chem 2008;283:14542–51.

    Google Scholar 

  14. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009;29:313–26.

    Google Scholar 

  15. Rosen LS. Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control 2002;9:36–44.

    Google Scholar 

  16. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005;46: 1118–22.

    Google Scholar 

  17. Liu Y, Peng W, Qu K, Lin X, Zeng Z, Chen J, et al. TET2: a novel epigenetic regulator and potential intervention target for atherosclerosis. DNA Cell Biol 2018;37:517–23.

    Google Scholar 

  18. Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 2017;355:842–7.

    Google Scholar 

  19. Krishnan SM, Ling YH, Huuskes BM, Ferens DM, Saini N, Chan CT, et al. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovasc Res 2019;115:776–87.

    Google Scholar 

  20. Hassan N, Ali A, Withycombe C, Ahluwalia M, Al-Nasseri RH, Tonks A, et al. TET-2 up-regulation is associated with the anti-inflammatory action of Vicenin-2. Cytokine 2018;108:37–42.

    Google Scholar 

  21. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011;1813:878–88.

    Google Scholar 

  22. Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev 2011;22:189–95.

    Google Scholar 

  23. Munford RS. Endotoxemia—menace, marker, or mistake? J Leukoc Biol 2016;100:687–98.

  24. Magrone T, Jirillo E. The impact of bacterial lipolysaccharides on the endothelial system: pathological consequences and therapeutic countermeasures. Endocr Metab Immune Disord Drug Targets 2011;11:310–25.

    Google Scholar 

  25. Niu G, Chen X. Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets. 2010;11:1000–17.

    Google Scholar 

  26. Sun J, Wang DA, Jain RK, Carie A, Paquette S, Ennis E, et al. Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors. Oncogene. 2005;24:4701–9.

    Google Scholar 

  27. Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 2017;377:111–21.

    Google Scholar 

  28. Jaiswal S, Libby P. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat Rev Cardiol 2019.

  29. Elkady AI, Hussein RA, El-Assouli SM. Mechanism of action of Nigella sativa on human colon cancer cells: the suppression of AP-1 and NF-κB transcription factors and the induction of cytoprotective genes. Asian Pac J Cancer Prev 2015;16:7943–57.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences, Cardiff Metropolitan University, Western Avenue, CF5 2YB, Cardiff, UK

    Jason Amartey, Samuel Gapper, Nurudeen Hussein, Keith Morris & Cathryn E. Withycombe

  2. Technical Support, R&D, Ortho Clinical Diagnostics, Felindre Meadows, CF35 5PZ, Pencoed, Bridgend, UK

    Nurudeen Hussein

Authors
  1. Jason Amartey
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Samuel Gapper
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Nurudeen Hussein
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Keith Morris
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Cathryn E. Withycombe
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Keith Morris.

Additional information

Peer review under responsibility of the Association for Research into Arterial Structure and Physiology

Data availability statement: All data can be made readily available through corresponding author (KM, CW and JA).

Rights and permissions

This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amartey, J., Gapper, S., Hussein, N. et al. Nigella sativa Extract and Thymoquinone Regulate Inflammatory Cytokine and TET-2 Expression in Endothelial Cells. Artery Res 25, 157–163 (2019). https://doiorg.publicaciones.saludcastillayleon.es/10.2991/artres.k.191114.002

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.2991/artres.k.191114.002

Keywords

Artery Research

ISSN: 1876-4401

Contact us